Related Experiment Video
Updated: Jul 30, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Patient Perceptions of Telehealth for Pediatric Type 1 Diabetes During the COVID-19 Pandemic: A Follow-up Study
Sajad Niyyati1, Alex Fung1, Qian Zhang2
1Division of Endocrinology, Department of Pediatrics, British Columbia Children's Hospital and University of British Columbia, Vancouver, British Columbia, Canada.
Insights
Pediatric diabetes telehealth use and satisfaction increased during the COVID-19 pandemic. Families increasingly prefer virtual visits for future diabetes care, with 80% desiring continued telehealth options.
Area of Science:
- Pediatric Endocrinology
- Digital Health
- Health Services Research
Background:
- The COVID-19 pandemic accelerated the adoption of pediatric diabetes telehealth.
- Initial studies indicated good usability and patient satisfaction with early telehealth services.
Purpose of the Study:
- To assess changes in telehealth usability over time.
- To evaluate shifts in patient preferences for future telehealth care in pediatric diabetes management.
Main Methods:
- A telehealth questionnaire was administered at two time points, more than one year apart.
- Survey data were linked with a clinical data registry.
- Statistical models were used to analyze the association between telehealth exposure and usability/preference.
Main Results:
- Virtual visit utilization rose from 46% to 92% of all telehealth visits.
- Virtual visits showed significant improvements in ease of use and satisfaction.
- The likelihood of preferring more future telehealth visits was 5.1 times higher in the later pandemic group.
Conclusions:
- Increased exposure to telehealth during the pandemic led to a greater desire for its continued use in pediatric diabetes care.
- Virtual care emerged as the preferred modality for many families.
- These findings offer valuable family perspectives for future telehealth development in diabetes care.
Objectives:
There was rapid uptake of pediatric diabetes telehealth at the onset of the COVID-19 pandemic and initial studies demonstrated good usability and satisfaction. As exposure to telehealth continued to increase during the pandemic, we aimed to determine changes in telehealth usability and changes in future preferences for telehealth care.
Methods:
A telehealth questionnaire was administered early in the pandemic and again more than 1 year later. Survey data were linked with a clinical data registry. A multivariable proportional odds logistic mixed-effects model was used to assess the association between exposure to telehealth and outcome of future preference for telehealth. Multivariable linear mixed-effects models were used to examine associations between exposure to early and later pandemic periods and the outcome of usability scores.
Results:
Survey response rate was 40%, with 87 early and 168 later period participants. Virtual visits increased from 46% to 92% of all telehealth visits. Virtual visits improved in "ease of use" (p=0.0013) and "satisfaction" (p=0.045); there were no improvements in telephone visits. The odds of indicating higher preference for more future telehealth visits was 5.1-fold higher in the later pandemic group (p=0.0298). Eighty percent of participants would like their future care to include telehealth visits.
Conclusions:
At our tertiary diabetes centre, families' desire for future telehealth care has increased during this 1-year period of additional telehealth exposure, and virtual care has now become the preferred option. This study provides important family perspectives that can help guide development of future diabetes clinical care.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Current Trends in Nursing II
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes: Symptoms, Diagnosis, and Complications

